Fred Hutchinson Cancer Center: Infections trials

The registry lists 10 Infections studies with Fred Hutchinson Cancer Center as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 2Phase 3 5Phase 4 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• NT-I7 for Kaposi Sarcoma in Patients With or Without HIVTerminatedNCT04893018Phase 1Results posted
• Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol UseCompletedNCT02744040Not applicableResults posted
• Vaccine Responsiveness After CAR-T Cell TherapyCompletedNCT04410900Phase 1
• Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in UgandaCompletedNCT02316444Phase 4
• Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV InfectionNo longer availableNCT00547235
• Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow TransplantCompletedNCT00209352Phase 3
• Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00045292Phase 3
• Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell TransplantationCompletedNCT00016081Phase 3
• Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell TransplantationCompletedNCT00016068Phase 3
• Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow TransplantationCompletedNCT00003883Phase 3